Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07397910

Clinical Trial on a Natural Compound to Improve Chronic Inflammation After SARS-CoV-2 Infection

Clinical Trial to Analyze the Effectiveness of a Natural Compound on Chronic Immune-mediated Inflammatory Status in Subjects Who Have Had SARS-CoV-2 Infection.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Universidad Católica San Antonio de Murcia · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

A controlled, randomized clinical trial is proposed to demonstrate the effectiveness of the experimental product in controlling hepato-pulmonary inflammation and neurovascular encephalic inflammation, which may constitute the etiopathogenic basis of persistent COVID. In addition, an individualized training program will be implemented for each participant in order to improve chronic symptoms and, consequently, their quality of life.

Detailed description

Randomized, placebo-controlled, double-blind clinical trial with four parallel arms based on the product consumed (placebo or experimental product) and the performance of physical exercise (exercise or no exercise), designed to analyze the effectiveness of the product under investigation in reducing chronic immune-mediated inflammatory status in subjects who have had SARS-CoV-2 infection and present persistent symptoms 3 months after the onset of the infectious process. The efficacy of the experimental product, consumed over a period of 4 months, will be determined in terms of reducing chronic inflammation and improving the quality of life of people suffering from this condition. Clinical manifestations and chronic symptoms, quality of life, response to the individualized physical exercise program, and product safety will be taken into account.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTExperimental ProductSupplement consisting of orange extract, apigenin, luteolin, yerba mate extract, grapefruit extract, and olive leaf extract.
DIETARY_SUPPLEMENTControl placeboProduct with identical characteristics to the experimental product.
OTHERPhysical exerciseDuring the study, subjects will have to develop a training program. A multicomponent program will be carried out during the 4 months of product consumption. The sessions will last 60 minutes and will be held 2-3 times per week.
OTHERNo Physical ExerciseDuring the study, subjects will only consume the product assigned to them in the randomization.

Timeline

Start date
2026-02-23
Primary completion
2026-07-06
Completion
2026-08-03
First posted
2026-02-09
Last updated
2026-02-09

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07397910. Inclusion in this directory is not an endorsement.